Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme Borreliosis in Italy

New Microbiologica

Volumn 28, Issue 1, 2005, Pages 37-43

  Marangoni, Antonella ^a   Sparacino, Monica ^a   Mondardini, Valeria ^b   Cavrini, Francesca ^a   Storni, Elisa ^a   Donati, Manuela ^a   Cevenini, Roberto ^a   Sambri, Vittorio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN MARTINO HOSPITAL   (Italy)

Author keywords

Borreliosis; C6 peptide; Enzyme linked immunosorbent assay; Lyme; Recombinant VlsE; Western Blotting

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY DETECTION; ANTIMICROBIAL THERAPY; ARTICLE; BLEEDING; BORRELIA BURGDORFERI; BORRELIA INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTERMETHOD COMPARISON; LYME DISEASE; MALE; NONHUMAN; PROSPECTIVE STUDY; WESTERN BLOTTING;

ADULT; AGED; ANTIBODIES, BACTERIAL; BLOTTING, WESTERN; BORRELIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ITALY; LYME DISEASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VIRUS CULTIVATION;

BORRELIA; BORRELIA BURGDORFERI;

EID: 14844289526     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. AGUERO-ROSENFELD, M.E., NOWAKOWSKI, J., BITTKER, S., COOPER, D., NADELMAN, R.B., AND WORMSER, G.P. (1996). Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. Journal of Clinical Microbiology, 34, 1-9.
2. BACON, R.M., BIGGERSTAFF, B.J., SCHRIEFER, M., GILMORE, R.D., PHILIPP, M.T., STEERE, A., WORMSER, G.P., MARQUES, A.R., AND JOHNSON, B.J.B. (2003). Improved serodiagnosis of Lyme disease by kinetic ELISAs using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with two-tiered testing. Journal of Infectious Diseases, 187, 1187-1199.
3. BARANTON, G., POSTIC, D., SAINT GIRONS, I., BOERLIN, P., PIFFARETTI, J.C., ASSOUS, M., AND GRIMONT, P.A.D. (1992). Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. International Journal of Systematic Bacteriology, 42, 378-383.
4. CENTERS FOR DISEASE CONTROL AND PREVENTION (1995). Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morbidity and Mortality Weekly Report, 44, 590-591.
5. CEVENINI, R., SAMBRI, V., MASSARIA, F., FRANCHINI, R., D'ANTUONO, A., BORDA, G., AND NEGOSANTI, M. (1992). Surface immunofluorescence assay for diagnosis of Lyme disease. Journal of Clinical Microbiology, 33, 2456-2461.
6. CICERONI, L., CIARROCHI, S., CIERVO, A., MONDARDINI, V., GUZZO, F., CARUSO, G., MURGIA, R., AND CINCO, M. (2001). Isolation and characterization of Borrelia burgdorferi sensu lato strains in an area of Italy where Lyme borreliosis is endemic. Journal of Clinical Microbiology, 39, 2254-2260.
7. HAUSER, U., LEHNERT, G., AND WILSKE B. (1999). Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. Journal of Clinical Microbiology, 37, 2241-2247.
8. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London), 227, 680-685.
9. LAWRENZ, M.B., HARDHAM, J.M., OWENS, R.T., NOWAKOWSKI, J., STEERE, A.C., WORMSER, G.P., AND NORRIS, S.J. (1999). Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. Journal of Clinical Microbiology, 37, 3997-4004.
10. LIANG, F.T., STEERE, A.C., MARQUES, A.R., JOHNSON, B.J., MILLER, J.N., AND PHILIPP, M.T. (1999). Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. Journal of Clinical Microbiology, 37, 3990-3996.
11. MAGNARELLI, L.A., MILLER, J.N., ANDERSON, J.F., AND RIVIERE, G.R. (1990). Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease. Journal of Clinical Microbiology, 28, 1276-1279.
12. MAGNARELLI, L.A., ANDERSON, J.F., JOHNSON, R.C., NADELMAN, R.B., AND WORMSER G.P. (1994). Comparison of different strains of Borrelia burgdorferi sensu lato used as antigens in enzyme-linked immunosorbent assays. Journal of Clinical Microbiology, 32, 1154-1158.
13. MAGNARELLI, L.A., IJDO, J.W., PADULA, S.J., FLAVELL, R.A., AND FIKRIG E. (2000). Serologic diagnosis of Lyme Borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. Journal of Clinical Microbiology, 38, 1735-1739.
14. MAGNARELLI, L.A., LAWRENZ, M., NORRIS, S.J., AND FIKRIG, E. (2002). Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. Journal of Medical Microbiology, 51, 649-655.
15. MARANGONI, A., SAMBRI, V., CIMMINO, C., CARUSO, G., MONDARDINI, V., AND CEVENINI, R. (1999). Evaluation of the immune response in culture-confirmed Lyme Borreliosis Erythema migrans patients. Zentralblatt für Bakteriologie, 289, 736-739.
16. MARCONI, R.T., AND GARON, C.F. (1992). Development of chain reaction primers sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. Journal of Clinical Microbiology, 30, 2830-2834.
17. MOGILYANSKY, E., LOA, C.C., ADELSON, M.E., MORDECHAI, E., AND TILTON, R.C. (2004). Comparison of Western Immunoblotting and the C6 Lyme Antibody test for laboratory detection of Lyme disease. Clinical and Diagnostic Laboratory Immunology, 11, 924-929.
18. NADELMAN, R.B., NOWAKOWSKI, J., FORSETER, G., GOLDBERG, N.S., BITTKER, S., COOPER, D., AGUERO-ROSENFELD, M., AND WORMSER G.P. (1996). The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. American Journal of Medicine, 100, 502-508.
19. NADELMAN, R.B., AND WORMSER, G.P. (1998). Lyme borreliosis. Lancet, 352, 557-565.
20. NORMAN, G.L., ANTIG, J.M., BIGAIGNON, G., AND HOGREFE, W.R. (1996). Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii western blots (immunoblots). Journal of Clinical Microbiology, 34, 1732-1738.
21. O'CONNELL, S., GRANSTROM, M., GRAY, J.S., AND STANEK G. (1998). Epidemiology of European Lyme borreliosis. Zentralblatt für Bakteriologie, 287, 229-240.
22. PELTOMAA, M., MC HUGH, G., AND STEERE, A.C. (2003). Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. Journal of Infectious Diseases, 187, 1178-1186.
23. PICKEN, R.N. (1992). Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. Journal of Clinical Microbiology, 30, 99-114.
24. SAMBRI, V., MARANGONI, A., OLMO, A., STORNI, E., MONTAGNANI, M., FABBI, M., AND CEVENINI R. (1999). Specific antibodies reactive with the 22-Kilodalton major outer surface protein of Borrelia anserina Ni-NL protect chicks from infection. Infection and Immunity, 67, 2633-2637.
25. SAMBRI, V., MARANGONI, A., EYER, C., REICHHUBER, C., SOUTSCHEK, E., NEGOSANTI, M., D'ANTUONO, A., AND CEVENINI R. (2001). Western immunoblotting with five Treponema pallidum recombinant antigens for serologic diagnosis of syphilis. Clinical and Diagnostic Laboratory Immunology, 8, 534-539.
26. SAMBRI, V., MARANGONI, A., GIACANI, L., GENNARO, R., MURGIA, R., CEVENINI, R., AND CINCO, M. (2002). Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. Journal of Antimicrobial Chemotherapy, 50, 895-902.
27. STANEK, G., AND STRLE, F. (2003). Lyme Borreliosis. Lancet, 362, 1639-1647.
28. STEERE, A.C., COBURN, J., AND GLICKSTEIN, L. (2004). The emergence of Lyme disease. Journal of Clinical Investigation, 113, 1093-1101.
29. STRLE, F., NELSON, J.A., RUZIC-SABLJIC, E., CIMPERMAN, J., MARASPIN, V., LOTRIC-FURLAN, S., CHENG, Y., PICKEN, M.M., TRENHOLME, G.M., AND PICKEN, R.N. (1996). European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans. Clinical Infectious Diseases, 23, 61-65.
30. TOWBIN, H., STAEHLIN, T., AND GORDON, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America, 76, 4350-4354.
31. WANG, G., VAN DAM, A.P., SCHWARTZ, I., AND DANKERT, J. (1999). Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clinical Microbiology Reviews, 12, 633-653.
32. WILSKE, B., ZÖLLER, L., BRADE, V., EIFFERT, M., GÖBEL, U.B., STANEK, G., AND PFISTER, H.W. (2000). MIQ 12 Lyme-Borreliose, p. 1-59. In Mauch, H. and Lütticken, R. Eds., Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. Urban & Fischer Verlag, Munich, Germany.
33. WORMSER, G.P., CARBONARO, C., MILLER, S., NOWAKOWSKI, J., NADELMAN, R.B., SIVAK, S., AND AGUERO-ROSENFELD, M.E. (2000). A limitation of 2-stage serological testing for Lyme disease: enzyme immunoassay and immunoblot assay are not independent tests. Clinical Infectious Diseases, 30, 545-548.
34. ZHANG, J.R., HARDHAM, J.M., BARBOUR, A.G., AND NORRIS, S.J. (1997). Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell, 89, 275-285.